Upadhyay Suketu
SEC CIK 1533149 · EDGAR
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
| 17 | Upadhyay Suketu | EVP, CFO | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-06 16:34 | 2026-05-04 | INCY | Incyte | Upadhyay Suketu | EVP, CFO | A - Grant | $0.00 | +26.3K | 26.3K | New | $0 |
| D | 2026-05-05 17:44 | 2026-05-01 | VRTX | Vertex Pharmaceuticals | Upadhyay Suketu | Dir | D - Sale to Iss | — | -796 | 1,558 | -34% | — |
| DM | 2026-03-10 | 2026-03-06 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $92.54 | -6,576 | 69.5K | -9% | -$608.5K |
| DM | 2026-03-10 | 2026-03-06 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +14.8K | 71.5K | +26% | $0 |
| D | 2026-02-27 | 2026-02-25 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +6,364 | 64.1K | +11% | $0 |
| D | 2026-02-27 | 2026-02-25 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $99.51 | -2,832 | 61.3K | -4% | -$281.8K |
| D | 2026-02-24 | 2026-02-20 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +5,445 | 60.2K | +10% | $0 |
| D | 2026-02-24 | 2026-02-20 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $98.62 | -2,446 | 57.8K | -4% | -$241.2K |
| D | 2025-11-12 | 2025-11-10 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +10.6K | 59.5K | +22% | $0 |
| D | 2025-11-12 | 2025-11-10 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $87.73 | -4,731 | 54.8K | -8% | -$415.1K |
| D | 2025-05-05 | 2025-05-01 | VRTX | Vertex Pharmaceuticals | Upadhyay Suketu | Dir | A - Grant | $0.00 | +796 | 3,355 | +31% | $0 |
| D | 2025-05-05 | 2025-05-01 | VRTX | Vertex Pharmaceuticals | Upadhyay Suketu | Dir | D - Sale to Iss | — | -1,001 | 2,354 | -30% | — |
| D | 2025-03-07 | 2025-03-06 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +4,560 | 50.9K | +10% | $0 |
| D | 2025-03-07 | 2025-03-06 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $104.86 | -2,029 | 48.9K | -4% | -$212.8K |
| D | 2025-02-24 | 2025-02-20 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +5,446 | 48.7K | +13% | $0 |
| D | 2025-02-24 | 2025-02-20 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $103.46 | -2,423 | 46.3K | -5% | -$250.7K |
| D | 2025-02-19 | 2025-02-18 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $101.00 | -8,155 | 43.3K | -16% | -$823.7K |
| D | 2025-02-19 | 2025-02-18 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +21.6K | 51.5K | +72% | $0 |
| D | 2024-11-12 | 2024-11-10 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +15.9K | 36.8K | +76% | $0 |
| D | 2024-11-12 | 2024-11-10 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $108.48 | -7,097 | 29.7K | -19% | -$769.9K |
| D | 2024-05-03 | 2024-05-01 | VRTX | Vertex Pharmaceuticals | Upadhyay Suketu | Dir | D - Sale to Iss | — | -1,168 | 2,559 | -31% | — |
| D | 2024-05-03 | 2024-05-01 | VRTX | Vertex Pharmaceuticals | Upadhyay Suketu | Dir | A - Grant | $0.00 | +1,001 | 3,727 | +37% | $0 |
| D | 2024-03-08 | 2024-03-06 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +4,561 | 22.7K | +25% | $0 |
| D | 2024-03-08 | 2024-03-06 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $125.82 | -1,919 | 20.8K | -8% | -$241.4K |
| D | 2024-02-27 | 2024-02-25 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +7,043 | 20.2K | +53% | $0 |
| D | 2024-02-27 | 2024-02-25 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $128.80 | -2,091 | 18.1K | -10% | -$269.3K |
| D | 2023-07-05 | 2023-07-01 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $146.51 | -1,677 | 13.0K | -11% | -$245.7K |
| D | 2023-07-05 | 2023-07-01 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +3,768 | 14.7K | +35% | $0 |
| 2023-05-03 | 2023-05-01 | VRTX | Vertex Pharmaceuticals | Upadhyay Suketu | Dir | A - Grant | $0.00 | +1,168 | 2,726 | +75% | $0 | |
| D | 2023-02-23 | 2023-02-21 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $124.73 | -1,155 | 10.9K | -10% | -$144.1K |
| D | 2023-02-23 | 2023-02-21 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +3,860 | 12.0K | +47% | $0 |
| D | 2022-07-05 | 2022-07-01 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +3,768 | 9,231 | +69% | $0 |
| D | 2022-07-05 | 2022-07-01 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $105.85 | -1,249 | 7,982 | -14% | -$132.2K |
| 2022-05-19 | 2022-05-18 | VRTX | Vertex Pharmaceuticals | Upadhyay Suketu | Dir | A - Grant | $0.00 | +1,558 | 1,558 | New | $0 | |
| D | 2021-07-02 | 2021-07-01 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | M - OptEx | $0.00 | +3,655 | 6,416 | +132% | $0 |
| D | 2021-07-02 | 2021-07-01 | ZBH | Zimmer Biomet | Upadhyay Suketu | EVP, CFO | F - Tax | $161.94 | -1,112 | 5,304 | -17% | -$180.1K |
Purchase Sale Sale after option exercise All abbreviations